CLINICAL, PARA-CLINICAL CHARACTERISTICS AND THE THRESHOLD OF HIGH-SENSITIVE TROPONIN T IN DIAGNOSTIC OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Kim Phuong Huynh1, Nhu Nghia Nguyen2, Bao Thuy Nguyen2,
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Chronic kidney disease is independent factor relating to increase in prevalence- mortality because of acute coronary syndrome. A determination of acute myocardial infarction in patients with chronic kidney disease is a challenge when a marker as Hs-TnT is interfered if kidney function decreases, as false positive rate increases. Objectives: To discribe clinical and para-clinical characteristics of acute myocardial infarction in patients with chronic kidney disease; to determine the cut point of Hs-TnT in diagnostic of acute myocardial infarction in patients with chronic kidney disease. Materials and methods: Cross sectional study on 60 patients with chronic kidney disease with reduced glomerular filtration rate, divided into 2 groups including acute myocardial infarction and non-acute myocardial infarction, at Can Tho Central General hospital and Can Tho University of Medicine and Pharmacy Hospital in 2022-2024. Results: NonST elevation myocardial infarction rate was higher, the chest pain symptom proportion was 66.7%, the mean Hs-TnT was 0.763 ng/ml, the mean eGFR was 35.249 ml/min/1.73m2, it had 22/30 patients supplied with coronary angiogram, in there, both 2-branch and 3-branch injuries were 26.7%. A new cut point of Hs-TnT for diagnosis of acute myocardial infarction in patients with chronic kidney disease was 0.162 ng/ml in general chronic kidney disease stage 3-5. Conclusions: Most acute myocardial infarction in chronic kidney disease occur in older adults and in patients with LDL-c wasn’t controlled well before the events happened, chest pain is the most complaint, the majority of these patients have diffuse coronary artery disease. A new cut point of Hs-TnT in diagnostic of acute myocardial infarction in patients with chronic kidney disease is different from and higher than it in the 99th percentile of general population.  

Article Details

References

1. Carney EF. The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020. 16(5), 251, doi: 10.1038/s41581-020-0268-7.
2. Centers for Disease Control and Prevention. Chronic kidney disease in the United States. 2021. https://nccd.cdc.gov/CKD/Documents/Chronic-Kidney-Disease-in-the-US-2021-h.pdf.
3. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020. 75(6), 1334-1357, doi: 10.1161/HYPERTENSIONAHA.120.15026.
4. Bộ Y Tế Việt Nam. Thực hành chẩn đoán và điều trị bệnh động mạch vành. 2020.
http://soytetuyenquang.gov.vn/van-ban-phap-quy/bo-y-te/quyet-dinh-so-5332-qd-byt-ve-viecban-hanh-tai-lieu-chuyen-m.html.
5. Ferrara LA, Staiano L, Di Fronzo V, Ferrara F, Sforza A, et al. Type of myocardial infarction presentation in patients with chronic kidney disease. Nutrition, Metabolism and Cardiovascular Diseases. 2015. 25(2), 148-152, doi: 10.1016/j.numecd.2014.11.002.
6. Twerenbold R, Wildi K, Jaeger C, Gimenez MR, Reiter M, et al. Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients with Renal Dysfunction. Circulation. 2015. 131(23), 2041-2050, doi: 10.1161/CIRCULATIONAHA.114.014245.
7. Hong LY, Jing L, Han L, Xiao XZ, Xi T, et al. Improving the diagnostic accuracy of acute myocardial infarction with the use of high-sensitive cardiac troponin T in different chronic kidney disease stages. Scientific Reports. 2017. 7(1), 41350, doi: 10.1038/srep41350.
8. Sosnov J, Lessard D, Goldberg RJ, Yarzebski J, Gore JM. Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective. American Journal of Kidney Diseases. 2006. 47(3), 378-384, doi: 10.1053/j.ajkd.2005.11.017.
9. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020. 41(1), 111–188, doi: 10.1093/eurheartj/ehz455.
10. Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2021. 42(14), 1289–1367, doi: 10.1093/eurheartj/ehaa575.